
TESA
No COA is linked to this product yet. Check the COA page or contact support if a document should be available.
Open COA pageSelect your amount and quantity.
TESA Research Overview
TESA is a synthetic growth-hormone-releasing hormone (GHRH) analog research peptide, stabilized against the rapid enzymatic breakdown that limits native GHRH in laboratory models. TESA is supplied for qualified in-vitro laboratory research and analytical use only.
Compound profile
- Compound class: Synthetic growth-hormone-releasing hormone (GHRH) analog
- Target: GHRH receptor (pituitary somatotrophs)
- Form: Lyophilized powder in a sealed vial
- Testing: Third-party HPLC purity and identity, batch-matched COA
Research context
GHRH analogs act on pituitary GHRH receptors to stimulate pulsatile growth-hormone release, which in turn drives hepatic IGF-1 production. TESA is studied in GH/IGF-axis signaling, lipid-regulation and visceral-adiposity research models. It is also available pre-blended with the ghrelin-receptor agonist Ipamorelin for paired GHRH/secretagogue studies.
Storage and handling
Store unopened lyophilized vials sealed and protected from light — at −20 °C for long-term storage, or 2–8 °C for short-term use. Once reconstituted, keep refrigerated at 2–8 °C, minimize freeze–thaw cycles and rely on your laboratory’s own validated stability data.
Quality and documentation
Every lot is third-party tested, and the Certificate of Analysis is matched to the exact batch you receive — look it up any time on the COA page. Browse more GH / IGF Axis Research, or see related compounds: Tesa / IPA 10MG / 3MG, Sermo.
Research Use Only Notice: Not for human consumption, not for veterinary use, not for clinical or diagnostic use, and not intended as a drug, food, dietary supplement, cosmetic, or household product. Purchaser is responsible for confirming lawful use, handling requirements, and regulatory status before purchase or use.